MedPath

A comparison of the efficacy of dietary hydroxypropylcellulose and questran as therapeutic agents in bile acid induced diarrhoea - Hydroxypropylcellulose and questran compared

Phase 1
Conditions
these patients will have bile acid induced diarrhoea identified by an increased serum 7a-OH-cholestenone.and will have a history of one of 1. ileal resection 2. idiopathic bile acid diarrhoea.3. post cholecystectomy diarrhoea
Registration Number
EUCTR2004-001054-84-GB
Lead Sponsor
HS Lothian- University Hospitals Division
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Patients will have bile acid induced diarrhoea - frequently passing 5-7 watery stools per day
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

less than 16 years in age

currently taking other anti diarrhoeals eg loperamide

presence of active inflammation

currently using anti inflammatory agents such as prednisolone.

5-ASA or azothioprine will be allowed if patient is in remission

Patients unable to give informed consent

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To compare the effectiveness of hydroxypropylcellulose and questran in reducing diarrhoea in different groups of patients with bile acid malabsorption.<br><br>is HPC asuitable alternative to questran in these clinical circumstances?;Secondary Objective: Is the action of hydroxypropyl cellulose different from questran? - measurement of serum 7a-OH-cholestenone a marker of bile acid turnover, should help answer this question;Primary end point(s): reduction in diarrheoa<br>Reduction in defaecation urgency<br>reduction in stool frequency<br>improved quality of life
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath